CD8A and prostate cancer: CD8+ cytotoxic T lymphocytes (CTLs) are central to tumor cell killing via perforin and granzyme delivery; studies using DNA vaccines targeting PSMA or PAP in prostate cancer confirm that vaccine-induced CD8+ T cells infiltrate tumors and mediate cytotoxicity [15,16].